World Journal of Surgery

, Volume 37, Issue 2, pp 392–397 | Cite as

Selective Mediastinal Lymphadenectomy Without Intraoperative Frozen Section Examinations for Clinical Stage I Non-Small-Cell Lung Cancer: Retrospective Study of 403 Cases

Article
  • 306 Downloads

Abstract

Objective

The extent of mediastinal lymphadenectomy for clinical stage I non-small-cell lung cancer (NSCLC) remains controversial. This study explored the value of selective mediastinal lymphadenectomy from the clinical viewpoint.

Methods

From 2005 to 2008, a total of 403 patients diagnosed clinically as having stage I NSCLC underwent lobectomy and mediastinal lymph node dissection. Among them, 309 underwent complete mediastinal lymphadenectomy, and the other 94 underwent selective mediastinal lymphadenectomy. We compared the perioperative parameters and overall survival statistics for the two groups retrospectively.

Results

The two groups had no significant differences in sex, pathology, tumor location, or preoperative staging. The selective mediastinal lymphadenectomy group had an older average age, with a much higher rate of patients >70 years of age (p = 0.016). Also, the patients were apt to undergo thoracoscopic lobectomy (p = 0.044). This group had shorter operating times and less intraoperative bleeding. No significant differences in total drainage volume, length of hospital stay, or complication rates were found between the two groups. The mean follow-up periods were 35.8 ± 13.7 vs. 34.6 ± 17.2 months. Local and distant recurrence rates were 25.6 % vs. 30.9 %, respectively (p = 0.560). The 3-year and 5-year overall survival rates were 83.0 % and 74.6 % vs. 75.1 % and 68.5 %, respectively (p = 0.216).

Conclusions

For patients with clinical stage I NSCLC, selective mediastinal lymphadenectomy can reduce the trauma caused by the procedure, especially for elderly patients and those with co-morbidities. Survival was acceptable and was no worse than that after complete mediastinal lymphadenectomy. Our results need to be confirmed by prospective randomized controlled studies.

References

  1. 1.
    Rami-Porta R, Wittekind C, Goldstraw P (2005) Complete resection in lung cancer surgery: proposed definition. Lung Cancer 49:25–33PubMedCrossRefGoogle Scholar
  2. 2.
    Smythe WR (2003) Treatment of stage I non-small cell lung carcinoma. Chest 123(Suppl):181S–187SPubMedCrossRefGoogle Scholar
  3. 3.
    Izbicki JR, Passlick B, Pantel K et al (1998) Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg 227:138–144PubMedCrossRefGoogle Scholar
  4. 4.
    Sugi K, Nawata K, Fujita N et al (1998) Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg 22:290–295PubMedCrossRefGoogle Scholar
  5. 5.
    Darling GE, Allen MS, Decker PA et al (2011) Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trial. Chest 139:1124–1129PubMedCrossRefGoogle Scholar
  6. 6.
    Darling GE, Allen MS, Decker PA et al (2011) Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non–small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg 141:662–670PubMedCrossRefGoogle Scholar
  7. 7.
    Watanabe SI, Asamura H (2009) Lymph node dissection for lung cancer: significance, strategy, and technique. J Thorac Oncol 4:652–657PubMedCrossRefGoogle Scholar
  8. 8.
    Okada M, Tsubota N, Yoshimura M et al (1998) Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarcinal nodes in selective dissection. J Thorac Cardiovasc Surg 116:949–953PubMedCrossRefGoogle Scholar
  9. 9.
    Okada M, Sakamoto T, Yuki T et al (2006) Selective mediastinal lymphadenectomy for clinico-surgical stage I non–small cell lung cancer. Ann Thorac Surg 81:1028–1032PubMedCrossRefGoogle Scholar
  10. 10.
    Ishiguro F, Matsuo K, Fukui T et al (2010) Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non–small cell lung cancer: a large-scale retrospective cohort study applying a propensity score. J Thorac Cardiovasc Surg 139:1001–1006PubMedCrossRefGoogle Scholar
  11. 11.
    Okasaka T, Usami N, Taniguchi T et al (2010) Can non-performance of radical systematic mediastinal lymphadenectomy be justified in elderly lung cancer patients? An evaluation using propensity-based survival analysis. Eur J Cardiothorac Surg 38:27–33PubMedCrossRefGoogle Scholar
  12. 12.
    UICC (1997, 2002) TNM Classification of Malignant Tumors. 5th and 6th edns. Geneva, UICCGoogle Scholar
  13. 13.
    Allen MS, Darling GE, Pechet TT et al (2006) Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 81:1013–1020PubMedCrossRefGoogle Scholar
  14. 14.
    Defranchi SA, Cassivi SD, Nichols FC et al (2009) N2 disease in T1 non-small cell lung cancer. Ann Thorac Surg 88:924–928PubMedCrossRefGoogle Scholar
  15. 15.
    Inoue M, Minami M, Sawabata N et al (2010) Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer. Eur J Cardiothorac Surg 37:1445–1449PubMedCrossRefGoogle Scholar
  16. 16.
    Watanabe SI, Asamura H, Suzuki K et al (2005) The new strategy of selective nodal dissection for lung cancer based on segment-specific patterns of nodal spread. Interact Cardiovasc Thorac Surg 4:106–109PubMedCrossRefGoogle Scholar
  17. 17.
    Rusch VW, Growley J, Giroux DJ et al (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2:603–612PubMedCrossRefGoogle Scholar
  18. 18.
    Lee JG, Lee CY, Bae MK et al (2008) Validity of International Association for the Study of Lung Cancer proposals for the revision of N descriptors in lung cancer. J Thorac Oncol 3:1421–1426PubMedCrossRefGoogle Scholar
  19. 19.
    Zheng H, Wang LM, Bao F et al (2011) Re-appraisal of N2 disease by lymphatic drainage pattern for non-small-cell lung cancers: by terms of nodal stations, zones, chains, and a composite. Lung Cancer 74:497–503PubMedCrossRefGoogle Scholar
  20. 20.
    Aokage K, Yoshida J, Ishii G et al (2010) Subcarinal lymph node in upper lobe non-small cell lung cancer patients: is selective lymph node dissection valid? Lung Cancer 70:163–167PubMedCrossRefGoogle Scholar
  21. 21.
    Watanabe SI, Suzuki K, Asamura H (2008) Superior and basal segment lung cancers in the lower lobe have different lymph node metastatic pathways and prognosis. Ann Thorac Surg 85:1026–1031PubMedCrossRefGoogle Scholar
  22. 22.
    Ichinose J, Kohno T, Fujimori S et al (2010) Locoregional control of thoracoscopic lobectomy with selective lymphadenectomy for lung cancer. Ann Thorac Surg 90:235–239PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2012

Authors and Affiliations

  1. 1.Department of Thoracic Surgery, Zhongshan HospitalFudan UniversityShanghaiChina

Personalised recommendations